News
Novavax seeks approval in Australia as Indonesia gives green light
Novavax has completed it’s application to the Australian Therapeutic Goods Administration for provisional approval.
If successful, the vaccine would be the fourth approved jab in Australia, after AstraZeneca, Pfizer and Moderna.
It would also become the first protein-based vaccination eligible for use within the country.
Novavax, also announced they’ve recently filed for authorisation with the UK’s Medicines and Healthcare products Regulatory Agency, while the jab has been approved for emergency use within Indonesia.
“This submission brings Novavax significantly closer to delivering doses of the first protein-based COVID-19 vaccine to Australia and, along with this week’s filing for conditional marketing authorisation in the UK, brings us one step closer to our goal of ensuring broad global access to our vaccine,”
Novavax President and CEO Stanley C. Erck said in a statement.
The Novavax vaccine works as a two-dose jab, administered 21 days apart.
The vaccine is stored at 2C – 8C, which means existing cold chain channels can be used for the vaccine supply.
How effective is the Novavax jab in comparison to others?
According to the company’s clinical trial of 15,000 participants in Britain, the vaccine showed a 96.4 per cent efficacy against the original virus strain.
It also displayed 86.3 per cent effectiveness against the Alpha variant and 89.7 per cent efficacy overall.
While the biotech company claims a pivotal Phase 3 trial of 30,000 participants in the United States and Mexico showed a 100 per cent protection against moderate and severe disease, with a 90.4 per cent efficacy overall.
However, the company could not provide statistics against the current dominant Delta variant.
Australia’s multimillion-dollar campaign to attract Hollywood productions to its shores appears to be paying off.
The allure of Australia lies not only in its picturesque locations but also in its competitive financial incentives.
The government offers generous rebates and tax breaks to international productions, making it an attractive proposition for filmmakers looking to maximise their budgets.
Despite the recent intake of Hollywood productions down under such as ‘The Fall Guy’ and ‘Furiosa: A Mad Max Saga’, Aussie independents are still finding the space to carve their own creative path.
Rob Fantozzi joined the program to discuss the latest in Hollywood, and showcased his own upcoming project – ‘Omerta‘. #featured
-
Shows3 days agoThe Dragon’s Tale
-
News4 days ago
Does American media have TikTok bias?
-
News3 days ago
U.S. home prices surge 47%
-
News3 days ago
Portal between countries shut down after international flashing
-
News5 days ago
European elections loom: the rise of the far-right
-
Leaders4 days ago
What are the benefits of intermittent fasting?
-
Shows5 days ago
Return logistics: retail faces pressure
-
News5 days ago
Will the U.S. approve MDMA therapy?
